The Premier RBQM
Industry Event:
Now Available
on Demand.
Stay ahead on AI, global regulations, and the technology reshaping risk-based quality management (RBQM)—watch the RBQMLive26 sessions on demand now.
Stay ahead on AI, global regulations, and the technology reshaping risk-based quality management (RBQM)—watch the RBQMLive26 sessions on demand now.
Don’t worry. We’ve got you covered.
Executive Director and Professor,
Tufts CSDD
Director of Clinical Risk and Analytics,
Alnylam
Director of Operational Systems,
Takeda
Head of RBM and Business Capability Owner of Patient Data Monitoring,
Sanofi
Director, Risk Management Strategy,
BioNTech
Executive and Clinical Research Leader,
Parexel
Associate Director of Systems Quality and Data Integrity,
Biogen
Global Development Operations Inspection Excellence Lead,
Merck KGaA
What’s RBQMLive?
Our Founder and Sponsor:
CluePoints created RBQMLive to give the RBQM community a dedicated space to learn, debate, and advance the science of risk-based quality management. As the founding sponsor, CluePoints brings together the brightest minds in clinical trials, independent of any commercial agenda.
2026 Sessions: Watch on Demand
RBQM at a Turning Point: From Adoption to Operational Maturity E8 and E11 Potential Expansion
This session explores how RBQM has achieved widespread adoption and how companies and organizations are operationalizing risk-based approaches. The keynote examines where the industry stands today, why expectations and practices have shifted, and how regulatory tailwinds (e.g., ICH E6(R3)) and the rapid emergence of AI and real-world oversight, are redefining the RBQM landscape. From this session, you will gain a clear perspective on the next phases of RBQM and the organizational capabilities needed to succeed.
Speakers
Executive Director and Professor, Tufts CSDD
VP, Strategic Consulting, CluePoints
Beyond Adoption: Proving the Value of a Mature RBQM Program (Panel)
Organizations have largely implemented RBQM, but achieving measurable value requires moving beyond compliance toward operational excellence. This discussion explores how leading sponsors are advancing their RBQM programs, overcoming common barriers, and building mature, scalable risk management practices. Panelists share lessons learned around governance, organizational change, cross-functional collaboration, and how they build and defend the business case to finance and quality leadership.
Speakers
Head of RBM and Business Capability Owner of Patient Data Monitoring, Sanofi
Director of Operational Systems, Takeda
Director of Clinical Risk and Analytics, Alnylam
RBQM Market Owner & Strategy Lead, CluePoints
Trusted AI in Clinical Operations: From Automation to Decision Intelligence
AI is rapidly moving from experimentation to practical application across clinical development. This session explores how organizations are implementing AI responsibly while improving efficiency, consistency, and decision-making. Speakers discuss governance, validation, transparency, auditability, continuous monitoring, and what sponsors need from AI vendors to confidently integrate AI into regulated clinical processes.
Speakers
Executive and Clinical Research Leader, Parexel
Director, Risk Management Strategy, BioNTech
Market Owner for Clinical Data Strategy, CluePoints
Designing Quality: From Inspection Readiness to Predicting Risk Before First Patient (Panel)
Inspection readiness is no longer about preparing for an audit. It is about continuously understanding and managing quality risk throughout a study. This session explores how organizations are shifting from reactive compliance to predictive quality management, using historical study data and protocol intelligence to identify emerging risk before they affect execution, and increasingly to design risk out at the protocol stage. Panelists discuss how early risk visibility improves planning, oversight, and regulatory confidence.
Speakers
Global Development Operations Inspection Excellence Lead, Merck KGaA
Associate Director of Systems Quality and Data Integrity, Biogen
Your RBQM Guides
Ken Getz
Tufts CSDD, Executive Director and Professor
At Tufts Center for the Study of Drug Development, Ken conducts grant-funded research across a range of clinical research and trial execution topics. He is also the founder and chairman of CISCRP, a non-profit organization that educates and raises awareness of the clinical research enterprise, and has extensive published work across the clinical research industry.
Miguel Valenzuela
Alnylam, Director of Clinical Risk and Analytics
Miguel has over 25 years of industry experience and has led the development and implementation of the RBQM approach at Alnylam since 2019.
Jamie O’Neill
Takeda, Director of Operational Systems
Jamie has over 20 years in pharmaceutical R&D with more than a decade focused on RBQM, system ownership, digital transformation, and organizational change management.
Demi You
Sanofi, Head of RBM and Business Capability Owner of Patient Data Monitoring
Demi has over 15 years of experience in clinical trial operations and drug development and has successfully driven RBQM adoption to over 90% across the company’s global portfolio.
Brian Barnes
BioNTech, Director, Risk Management Strategy
Brian brings 19 years of clinical development experience and over 12 years of expertise in RBQM. He specializes in operational solutions for pharma, biopharma, and biotech companies.
Cris McDavid
Parexel, Executive and Clinical Research Leader
Cris has over 20 years of global clinical trial delivery experience and currently leads Parexel’s RBQM operations, driving process and technology implementation.
Tom Whitman
Biogen, Associate Director of Systems Quality and Data Integrity
At Biogen, Tom specializes in RBQM and Quality by Design. His experience includes quality governance, vendor oversight, data integrity, and process improvement across clinical development.
Kris Luypaert
Merck KGaA, Global Development Operations Inspection Excellence Lead
At Merck KGaA, Kris develops integrated approaches to help trial teams prepare for and conduct regulatory inspections, drawing on leadership experience across clinical operations, quality and compliance, and risk management in pharma and large CRO settings.
Want to Speak at the Next RBQMLive or Other CluePoints Events?
"*" indicates required fields







